Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19832737rdf:typepubmed:Citationlld:pubmed
pubmed-article:19832737lifeskim:mentionsumls-concept:C0228174lld:lifeskim
pubmed-article:19832737lifeskim:mentionsumls-concept:C0205527lld:lifeskim
pubmed-article:19832737lifeskim:mentionsumls-concept:C0015846lld:lifeskim
pubmed-article:19832737lifeskim:mentionsumls-concept:C0600097lld:lifeskim
pubmed-article:19832737lifeskim:mentionsumls-concept:C1442792lld:lifeskim
pubmed-article:19832737lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:19832737lifeskim:mentionsumls-concept:C0002928lld:lifeskim
pubmed-article:19832737pubmed:issue12lld:pubmed
pubmed-article:19832737pubmed:dateCreated2010-1-22lld:pubmed
pubmed-article:19832737pubmed:abstractTextThis study investigated the effect of intrathecal fentanyl on the dose of propofol during sedation guided by Cerebral State Index monitoring. Seventy patients were randomly assigned to receive either fentanyl 25 microg (n = 35) or normal saline (n = 35) with hyperbaric bupivacaine 12.5 mg for spinal anaesthesia. Propofol was infused to maintain a Cerebral State Index value of 65-75 for 30 min. The propofol infusion time and dose required to reach a Cerebral State Index value of 75 were recorded together with the time required to reach a Cerebral State Index value higher than 90 after cessation of sedation. The onset time for sedation was faster and the recovery time was slower in the fentanyl group compared to those in the saline group (p = 0.018 and 0.027, respectively). The propofol doses required for onset and maintenance of sedation were significantly lower in the fentanyl group compared to those in the control group (p = 0.018 and < 0.001, respectively). In conclusion, adding intrathecal fentanyl 25 microg during spinal anaesthesia significantly reduced the dose of propofol required for sedation and prolonged the subsequent recovery time.lld:pubmed
pubmed-article:19832737pubmed:languageenglld:pubmed
pubmed-article:19832737pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19832737pubmed:citationSubsetAIMlld:pubmed
pubmed-article:19832737pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19832737pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19832737pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19832737pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19832737pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19832737pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19832737pubmed:statusMEDLINElld:pubmed
pubmed-article:19832737pubmed:monthDeclld:pubmed
pubmed-article:19832737pubmed:issn1365-2044lld:pubmed
pubmed-article:19832737pubmed:authorpubmed-author:LeeJ SJSlld:pubmed
pubmed-article:19832737pubmed:authorpubmed-author:LalH MHMlld:pubmed
pubmed-article:19832737pubmed:authorpubmed-author:ShinC SCSlld:pubmed
pubmed-article:19832737pubmed:authorpubmed-author:KimM KMKlld:pubmed
pubmed-article:19832737pubmed:authorpubmed-author:KimJ YJYlld:pubmed
pubmed-article:19832737pubmed:authorpubmed-author:KOS SSSlld:pubmed
pubmed-article:19832737pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19832737pubmed:volume64lld:pubmed
pubmed-article:19832737pubmed:ownerNLMlld:pubmed
pubmed-article:19832737pubmed:authorsCompleteYlld:pubmed
pubmed-article:19832737pubmed:pagination1307-11lld:pubmed
pubmed-article:19832737pubmed:meshHeadingpubmed-meshheading:19832737...lld:pubmed
pubmed-article:19832737pubmed:meshHeadingpubmed-meshheading:19832737...lld:pubmed
pubmed-article:19832737pubmed:meshHeadingpubmed-meshheading:19832737...lld:pubmed
pubmed-article:19832737pubmed:meshHeadingpubmed-meshheading:19832737...lld:pubmed
pubmed-article:19832737pubmed:meshHeadingpubmed-meshheading:19832737...lld:pubmed
pubmed-article:19832737pubmed:meshHeadingpubmed-meshheading:19832737...lld:pubmed
pubmed-article:19832737pubmed:meshHeadingpubmed-meshheading:19832737...lld:pubmed
pubmed-article:19832737pubmed:meshHeadingpubmed-meshheading:19832737...lld:pubmed
pubmed-article:19832737pubmed:meshHeadingpubmed-meshheading:19832737...lld:pubmed
pubmed-article:19832737pubmed:meshHeadingpubmed-meshheading:19832737...lld:pubmed
pubmed-article:19832737pubmed:meshHeadingpubmed-meshheading:19832737...lld:pubmed
pubmed-article:19832737pubmed:meshHeadingpubmed-meshheading:19832737...lld:pubmed
pubmed-article:19832737pubmed:meshHeadingpubmed-meshheading:19832737...lld:pubmed
pubmed-article:19832737pubmed:meshHeadingpubmed-meshheading:19832737...lld:pubmed
pubmed-article:19832737pubmed:meshHeadingpubmed-meshheading:19832737...lld:pubmed
pubmed-article:19832737pubmed:meshHeadingpubmed-meshheading:19832737...lld:pubmed
pubmed-article:19832737pubmed:meshHeadingpubmed-meshheading:19832737...lld:pubmed
pubmed-article:19832737pubmed:meshHeadingpubmed-meshheading:19832737...lld:pubmed
pubmed-article:19832737pubmed:year2009lld:pubmed
pubmed-article:19832737pubmed:articleTitleThe effect of intrathecal fentanyl on Cerebral State Index-guided sedation during spinal anaesthesia.lld:pubmed
pubmed-article:19832737pubmed:affiliationDepartment of Anaesthesiology and Pain Medicine, Anaesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea.lld:pubmed
pubmed-article:19832737pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19832737pubmed:publicationTypeRandomized Controlled Triallld:pubmed